2023
DOI: 10.1016/j.bjid.2023.102787
|View full text |Cite
|
Sign up to set email alerts
|

Brazil needs to be vaccinated

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…To our knowledge, there is no contraindication for administering the COVID-19 vaccine to patients undergoing PEP, or for providing PEP to those receiving the COVID-19 vaccine. In Brazil, the use of well-established vaccines in the National Vaccine Program declined due to hesitancy associated with the COVID-19 vaccine 25 . Data on PEP acceptance in Brazil are limited, and the potential impact of vaccination hesitancy on patients requiring PEP for HR cannot be discounted.…”
Section: Covid-19 Impact On Post-exposure Prophylaxis Worldwidementioning
confidence: 99%
“…To our knowledge, there is no contraindication for administering the COVID-19 vaccine to patients undergoing PEP, or for providing PEP to those receiving the COVID-19 vaccine. In Brazil, the use of well-established vaccines in the National Vaccine Program declined due to hesitancy associated with the COVID-19 vaccine 25 . Data on PEP acceptance in Brazil are limited, and the potential impact of vaccination hesitancy on patients requiring PEP for HR cannot be discounted.…”
Section: Covid-19 Impact On Post-exposure Prophylaxis Worldwidementioning
confidence: 99%
“… 13 Previous studies in Brazil have indicated the association between political ideology and willingness to take the COVID-19, 9 , 14 negatively affecting the need for fast vaccination from the Brazilian population. 15 In the Brazilian case of the vaccination process, understanding the variables that influence confidence in the predisposition to take vaccines is fundamental. 16 Therefore, among these factors, political positioning 16–19 and characteristics of the available vaccines (country of origin, developing company, speed, lack of information, and efficacy) 16–18 stand out.…”
Section: Introductionmentioning
confidence: 99%